Government of Sindh reported on Monday two deaths due to coronavirus in Karachi bringing the total number of deaths in the province to five.
The patients 52 and 66 years old were diagnosed with the virus three days ago, Sindh’s Minister for Health and Population Welfare Dr Azra Pechuho said. They both contracted the infection at the Raiwind moot.
We can confirm 2 more deaths in #Karachi from #COVID19 as of this morning. The 66 and 52 year old had underlying renal & respiratory diseases & had acquired #COVID19 through contact at the Raiwand Ijtima. This brings the total number of deaths in #Sindh to 5. #SindhHealth
— Health and Population Welfare Department, Sindh (@SindhHealthDpt) March 30, 2020
Similalry, Punjab reported 45 more cases of coronavirus on Monday, taking the provincial tally to 638. This was confirmed by provincial health department spokesperson Qaiser Asif, local media reported.
Latest updates of coronavirus in Pakistan
Currently, Pakistan has been facing acute ad exponential increase of Coronavirus. More than 1650 cases of coronavirus patients have been reported thus far. Among these numbers, 19 persons have reportedly lost their lives in the country.
Meanwhile, the situation is worrisome at provincial level as the lethal virus has grabbed Punjab and it has reported 638 cases followed by Sindh which has 508 reported cases of Covid-19.
The cases in Baluchistan have also increased to 144 and in KPK , the cases of Corona infected patients reached to 195. Similarly, the virus has also spread its jaws to GB, where 128 cases have been reported so far. Islamabad has 51 cases of the virus, while Azad Jammu &Kashmir has only 6 cases as of Monday.
Treatment of Coronavirus
A limited emergency-use authorization for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients.
In a statement published Sunday, the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile — including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments.
It said the FDA had allowed them “to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”